Atlas Trials

Investigation of the Timely-coordinated Therapy of Patients With Metastatic Cancer by Radiotherapy Together With Immune Checkpoint Inhibition

Clinical trial NCT03453892 · COMPLETED

Trial details

NCT number
NCT03453892
Sponsor
University of Erlangen-Nürnberg Medical School
Status
COMPLETED
Study type
OBSERVATIONAL
Metastatic Cancer
Start date
2017-04-01
Primary completion
2021-02-28
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.